BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31385929)

  • 1. DSA-FXM: Accelerated Donor-specific Flow Crossmatch Discriminating Class I and II Antibody Specifically and Only to Donor HLA for Determining True Incompatibility.
    Chen G; Lin L; Tyan DB
    Transplantation; 2020 Apr; 104(4):813-822. PubMed ID: 31385929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical utility and thresholds of virtual and Halifaster flow crossmatches in lung transplantation.
    Hiho SJ; Levvey B; Carroll R; Nicolson I; Mihaljcic M; Diviney MB; Snell GI; Sullivan LC; Westall GP
    HLA; 2022 Jun; 99(6):580-589. PubMed ID: 35340124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive virtual crossmatch with negative flow crossmatch results in two cases.
    Jacob EK; De Goey SR; Gandhi MJ
    Transpl Immunol; 2011 Jul; 25(1):77-81. PubMed ID: 21641997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes.
    Gandhi MJ; DeGoey SR; Bundy K; Kremers WK; Knauer R; Pereira N; Edwards B; Kushwaha S; Daly RC
    Transplant Proc; 2011 Dec; 43(10):3840-6. PubMed ID: 22172857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
    Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD
    Transplantation; 2004 Jul; 78(2):221-7. PubMed ID: 15280682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing transplantation of sensitized heart candidates using 4 antibody detection assays to prioritize the assignment of unacceptable antigens.
    Reinsmoen NL; Patel J; Mirocha J; Lai CH; Naim M; Ong G; Wang Q; Zhang X; Liou F; Yu Z; Kobashigawa J
    J Heart Lung Transplant; 2016 Feb; 35(2):165-72. PubMed ID: 26683810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.
    Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W
    Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual and Reality: An Analysis of the UCLA Virtual Crossmatch Exchanges.
    Locke AF; Hickey M; Valenzuela NM; Butler C; Sosa R; Zheng Y; Gjertson D; Reed EF; Zhang Q
    Transplantation; 2023 Aug; 107(8):1776-1785. PubMed ID: 36944607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients.
    Cordero E; Bulnes-Ramos A; Aguilar-Guisado M; González Escribano F; Olivas I; Torre-Cisneros J; Gavaldá J; Aydillo T; Moreno A; Montejo M; Fariñas MC; Carratalá J; Muñoz P; Blanes M; Fortún J; Suárez-Benjumea A; López-Medrano F; Roca C; Lara R; Pérez-Romero P
    Front Immunol; 2020; 11():1917. PubMed ID: 33123119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-Year Outcomes of Living Related Kidney Transplant in Patients With Preformed HLA Donor-Specific Antibodies: A Single-Center Experience in Malaysia.
    Jalalonmuhali M; Ng KP; Mohd Shariff NH; Lee YW; Wong AH; Gan CC; Lim SK
    Transplant Proc; 2020; 52(6):1718-1722. PubMed ID: 32448671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement-dependent cytotoxicity crossmatch in solid organ transplantation: The gold standard or golden history?
    Tafulo S; Osório E; Mendes C; Liwski R
    Hum Immunol; 2024 Jan; 85(1):110734. PubMed ID: 38030522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative performance evaluation of a donor-specific bead-based crossmatch technique for the detection of donor-specific anti-HLA antibodies in heart transplantation.
    Chaidaroglou A; Skoura A; Degiannis D
    Transplant Proc; 2013 Jun; 45(5):2005-8. PubMed ID: 23769095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitizing With Temporary Donor Splenic Transplant: Hope for the Sensitized Patients on Pancreas and Kidney -Pancreas Transplant Waitlist.
    Di Cocco P; Gaitonde S; Spaggiari M; Fratti A; Alvarez JA; Petrochenkov E; Valdenepas BT; Gupta P; Benedetti E; Tzvetanov I
    Transplant Proc; 2023 Mar; 55(2):295-302. PubMed ID: 36801174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luminex Solid-Phase Crossmatch for De Novo Donor-Specific Antibodies in Living-Donor Related Transplants.
    Mehrotra S; Sharma RK; Mayya M; Gupta A; Prasad N; Kaul A; Bhadauria DS
    Exp Clin Transplant; 2017 Aug; 15(4):394-399. PubMed ID: 28447925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
    Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
    Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual HLA Crossmatching as a Means to Safely Expedite Transplantation of Imported Pancreata.
    Eby BC; Redfield RR; Ellis TM; Leverson GE; Schenian AR; Odorico JS
    Transplantation; 2016 May; 100(5):1103-10. PubMed ID: 26950720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.